RESPIRATORY SYNCYTIAL VIRUS INFECTION
Clinical trials for RESPIRATORY SYNCYTIAL VIRUS INFECTION explained in plain language.
Never miss a new study
Get alerted when new RESPIRATORY SYNCYTIAL VIRUS INFECTION trials appear
Sign up with your email to follow new studies for RESPIRATORY SYNCYTIAL VIRUS INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New study tests best way to protect babies from RSV: vaccine during pregnancy, antibody at birth, or both?
Prevention OngoingThis study looks at the best way to protect babies from RSV, a serious lung infection. It compares giving a vaccine to pregnant women, giving a long-acting antibody to newborns, or using both. The goal is to see how well each approach works and how safe they are during the baby's…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS INFECTION
Phase: PHASE4 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Prevention
Last updated Apr 29, 2026 15:04 UTC
-
New study monitors RSV vaccine safety in seniors
Knowledge-focused OngoingThis study is monitoring 1,100 adults aged 60 and older who received the Abrysvo RSV vaccine in Japan. Researchers are tracking side effects for 28 days after vaccination to confirm the vaccine's safety in real-world conditions. No new treatment is being tested—this is a safety f…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS INFECTION
Sponsor: Pfizer • Aim: Knowledge-focused
Last updated May 13, 2026 16:03 UTC